White blood cell count and the risk of colon cancer

Yonsei Medical Journal

Volumn 47, Issue 5, 2006, Pages 646-656

  Lee, Yong Jae ^a   Lee, Hye Ree ^a   Nam, Chung Mo ^b   Hwang, Ue Kyoung ^c   Jee, Sun Ha ^d  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Colon cancer; Inflammation; White blood cell count

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLON CANCER; COLON CARCINOGENESIS; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; KOREA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; RECTUM CANCER; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RISK FACTORS; SMOKING;

EID: 33750685604     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.5.646     Document Type: Article

References (29)

1. National Cancer Information Center. 2002 Annual report of the Korea central cancer registry. Goyang: National Cancer Information Center, 2003. http://www.ncc.re.kr (accessed June 27, 2005)
2. Korea National Statistical Office. Death Statistics based on vital registration 2002. Daejeon: Korea National Statistical Office, 2003. http://kosis,nso.go.kr/cgi-bin/ sws_777pop.cgi?A_REPORT_ID=MA&A_CONTENTS=1501&A_LANG=1 (accessed June 27, 2005)
3. Durno C, Aronson M, Bapat B, Cohen Z, Gallinger S. Family history and molecular features of children, adolescents and young adults with colorectal carcinoma. Gut 2005;54:1146-50.
4. Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, Ellison RC, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 2004;28:559-67.
5. Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S. Diet and colorectal adenoma in Japanese males and females. Dis Colon Rectum 2001; 44:105-11.
6. Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, et al. Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br J Cancer 2003; 88:1038-43.
7. Luchtenborg M, Weijenberg MP, Kampman E, van Muijen GN, Roemen GM, Zeegers MP, et al. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am J Epidemiol 2005;161:806-15.
8. Slattery ML, Edwards S, Curtin K, Ma K, Eduward R, Holubkor R, et al. Physical activity and colorectal cancer. Am J Epidemiol 2003;158:214-24.
9. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202.
10. Levin B. Inflammatory bowel disease and colon cancer. Cancer 1992;70:1313-6.
11. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
12. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
13. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585-90.
14. Zhang SM, Buring JF, Lee IM, Cook NR, Ridker PM. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 2005;142:425-32.
15. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking, and myocardial infarction. N Engl J Med 1981;304:465-8.
16. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985,153:9-13.
17. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891-9.
18. Erlinger TP, Muntner P, Helzlsouer KJ. WBC and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev 2004;13:1052-6.
19. Oka M, Inaba A, Uchiyama T, Hazana S, Shimoda K, Suzuki M, et al. Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers. Am J Surg 1994;167:264-7.
20. Pugh S, Thomas GA. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut 1994;35:675-8.
21. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8.
22. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
23. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry 1998;63:854-65.
24. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA. The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 2005;26:1513-9.
25. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation. of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-6.
26. Verdaet D, Dendale P, De Bacquer D, Delanghe J, Block P, De Backer G. Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease. Atherosclerosis 2004; 176:303-10.
27. Wolever TM, Bolognesi C. Prediction of glucose and insulin responses of normal subjects after consuming mixed meals varying in energy, protein, fat, carbohydrate and glycemic index. J Nutr 1996;126:2807-12.
28. Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004;96:546-53.
29. Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13:279-84.